$IPIX Innovation Pharmaceuticals Plans for Phase 2 Trial of New Treatment for Ulcerative Colitis https://t.co/ihPtYtWbM6?amp=1Your Digital Self=============HUGE HEADS UP COMING SOON$IPIX$ Opinion: These are the steps needed for a vaccine to be approved 1 Published: Feb. 21, 2020 at 5:55 a.m. ET By Jurica Dujmovic A global effort is under way to develop a vaccine to treat the deadly coronaviru
Clinical Trials Arena lists endeavors from both pharmaceutical companies and research organizations such as the National Institutes of Health (NIH) in the U.S. GlaxoSmithKline GSK, -1.75%, Inovio Pharmaceuticals INO, +22.11%, Innovation Pharmaceuticals IPIX, +11.11%, Moderna MRNA, +1.89%, Novavax NVAX, +13.69%, Clover Biopharmaceuticals and Codagenix are just some of the names working on the development of the vaccine on their own or in partnerships with governments or other companies.